GEIST:UPC Searchengine

https-www.unifiedpatentcourt.org-en-node-549-1556e8b2d937

Dexcom, Inc. v. Abbott Laboratories, Abbott Diabetes Care inc, Abbott France, Abbott NV/SA, Abbott B.V, Abbott S.r.l, Abbott Sacandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics Gmbh, Abbott Logistics B.V

Datum
2023-12-19
Kammer
Paris (FR) Local Division
Verfahrensart
Infringement Action
Sprache
EN

Metadaten

Fall-IDhttps-www.unifiedpatentcourt.org-en-node-549-1556e8b2d937
Aktenzeichen
Registerzeichen
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 7

1 Paris local division UPC_CFI_230/2023 Order of the Court of First Instance of the Unified Patent Court delivered on 19-12-2023 APPLICANTS yDefendants in the main proceedingsz 1) Abbott Diabetes Care Inc. 1360 South Loop Road, Alameda, California 94502, USA, represented by its president Jared Watkin 2) Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6400, USA, represented by its board of directors which is represented by the CEO Robert Ford 3) Abbott France, incorporated as a S.A.S. ySociété par Actions Simplifiéez under no. 602 950 206 at the Business Register of Créteil, of 40/48 rue d'Arcueil, 94593 Rungis, France, represented by its president Philippe Emery 4) Abbott yN.V.), incorporated as a S.A. ySociété Anonymez under no. 0403.044.007, of Avenue Einstein 14,  ...